Imetelstat
Geron Corporation
['imerge', 'mds', 'imerge trial', 'valeria']
congress | #eha2023 valeria santini, presents results from the imerge trial. imetelstat was associated with cytogenetic response and reduction in mutational burden vs placebo in rbc-td, esa r/r or ineligible, len/hma na ve pts with non-del(5q) lr-mds. 
Lifting levels of knowledge in myelodysplastic syndromes (#MDS). A global online platform providing latest treatment options and medical information. #mdssm